We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MCO:NYSEMoody's Corporation analysis

Data as of Oct 19, 2026 - not real-time

Latest price
$481.45
Risk: low
3/10Low risk

Summary

The moving-average structure behind Moody's Corporation is neutral at $481.45, with no clear ordering between short and long averages. Across the trailing 30 sessions it lost 2.5%. Relative strength is 58.1 — neutral — and the MACD signal is bullish. Price has been bracketed by support at $438.01 and resistance at $490.85.
Multiples put this in overvalued territory: 30.5 times earnings against the sector's 15.7. Consensus targets land 14.5% above where the shares trade now. Revenue is growing at 15.1% on a 34.3% profit margin. The 0.85% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 3 — low. With 30-day volatility of 24.0%, a beta of 0.53 and a maximum drawdown of 23.6%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 89 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top market events

  • Second-quarter revenue reached USD 2.19 billion, up 15.10 percent year over year. Moody's stock cost
  • MCO stock costs EUR 434.50 on October 19, 2026 before results. Second-quarter revenue reached USD 2.
  • Moody’s Corporation NYSE:MCO sits behind one of the strongest moats in finance.

Market outlook

Short term

< 1 year

Neutral

Model confidence3/103 out of 10

Key factors

  • Trading above the 200-day average of 468.85
  • MACD momentum is positive
  • Maximum drawdown of 23.6%

Medium term

1–3 years

Neutral

Model confidence2/102 out of 10

Key factors

  • P/E of 30.5 versus sector average of 15.7
  • Trading above the 200-day average of 468.85
  • Analyst targets imply +14.5% versus the current price

Long term

> 3 years

Neutral

Model confidence1/101 out of 10

Key factors

  • P/E of 30.5 versus sector average of 15.7
  • Analyst targets imply +14.5% versus the current price
  • Profit margin of 34.3% is healthy

Key metrics

Financial health

Revenue Growth15.10%
Profit Margin34.25%
P/E Ratio30.5
ROE76.93%
ROA15.62%
Debt/Equity240.68
P/B Ratio27.6
Op. Cash Flow$3.3B
Free Cash Flow$2.6B
Industry P/E15.7

Technical analysis

TrendNeutral
RSI58.1
Support$438.01
Resistance$490.85
MA 20$462.88
MA 50$477.64
MA 200$468.85
MACDBullish
VolumeDecreasing
Fear & Greed Index88.89

Valuation

Fair Value$300.68
Target Price$551.38
Upside/Downside14.53%
GradeOvervalued
TypeGrowth
Dividend Yield0.85%

Risk assessment

Beta0.53
Volatility24.02%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.